Previous studies on adiponectin and apelin levels in OSA patients report conflicting results (21–24) while other few focusing on chemerin and SFRP5 in OSA patients, have been limited by the absence of multivariate adjustment or a smaller sample size (25, 26). The gene discussed is APLN; the disease is obstructive sleep apnea syndrome.